Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study

Osteoprotegerin, a potent osteoclast activation inhibitor, decreases bone resorption and positively affects bone mineral density. This study examined the association between serum osteoprotegerin levels and bone loss in patients with chronic kidney disease, a condition associated with increased risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chang Seong, Bae, Eun Hui, Ma, Seong Kwon, Han, Seung Hyeok, Choi, Kyu Hun, Lee, Joongyub, Chae, Dong Wan, Oh, Kook-Hwan, Ahn, Curie, Kim, Soo Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113973/
https://www.ncbi.nlm.nih.gov/pubmed/27855207
http://dx.doi.org/10.1371/journal.pone.0166792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113973/
https://www.ncbi.nlm.nih.gov/pubmed/27855207
http://dx.doi.org/10.1371/journal.pone.0166792

Ejemplares similares